BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7280329)

  • 1. [Modified Makari test in the diagnosis of tumors of mammary origin].
    Senra Varela A; Palmeiro Troitiño R; García-Blanco Saceda P; Millán Núñez-Cortés J
    Rev Clin Esp; 1981 May; 161(4):223-5. PubMed ID: 7280329
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of serum CA-50 measurement in breast diseases --relation to the progress of breast cancer].
    Shiga T; Kawauchi A; Kamiya K; Ishii J; Uzawa R; Gomi K
    Rinsho Byori; 1986 Nov; 34(11):1339-45. PubMed ID: 3469447
    [No Abstract]   [Full Text] [Related]  

  • 3. Humoral immunologic response in patients with tumors of the breast.
    Glazman H; Salwa J; Harlozińska A
    Arch Immunol Ther Exp (Warsz); 1973; 21(1):175-84. PubMed ID: 4720430
    [No Abstract]   [Full Text] [Related]  

  • 4. [Monoclonal antibodies in mammary carcinoma].
    Pancino G; Roseto A
    Medicina (B Aires); 1988; 48(3):311-20. PubMed ID: 3073296
    [No Abstract]   [Full Text] [Related]  

  • 5. [Distribution of so-called Thomsen-Friedenreich antigens in normal, diseased and carcinomatous breast tissue].
    Klein PJ; Newman RA; Müller P; Schaefer HE; Lennartz KJ; Uhlenbruck G; Fischer R
    Verh Dtsch Ges Pathol; 1978; 62():325. PubMed ID: 746856
    [No Abstract]   [Full Text] [Related]  

  • 6. Simultaneous assays of cancer associated antigens in benign and malignant breast diseases.
    Franchimont P; Zangerle PF; Hendrick JC; Reuter A; Colin C
    Cancer; 1977 Jun; 39(6 Suppl):2806-12. PubMed ID: 68808
    [No Abstract]   [Full Text] [Related]  

  • 7. A correlation of erythrocyte sedimentation and plasma carcinoembryonic antigen in fibrocystic disease and carcinoma of the breast.
    Thynne GS; Greening WP
    Clin Oncol; 1980 Dec; 6(4):317-21. PubMed ID: 7460405
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical importance of determination of antigens of cancerous origin].
    Franchimont P; Zangerlé PF; Hendrick JC; Proyard J
    Rev Med Liege; 1974 Dec; 29(23):725-38. PubMed ID: 4141115
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum antibody in patients with mammary disease.
    Humphrey LJ; Estes NC; Morse PA; Jewell WR; Boudet RA; Hudson MJ
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1516-20. PubMed ID: 4214083
    [No Abstract]   [Full Text] [Related]  

  • 10. Possibilities for estimating the appearance of distant metastases in mammary cancer by immunoglobulin G assay.
    Kiricuta I; Ionescu D; Mureşian T
    Arch Geschwulstforsch; 1972; 40(2):159-64. PubMed ID: 5081908
    [No Abstract]   [Full Text] [Related]  

  • 11. [Search for the heterogenetic Forssman antigen in human breast tumor tissue].
    Berdinskikh MS; Pavliuchenkova RP; Kiseleva AS; Kulakova AM; Kosiakov PN
    Biull Eksp Biol Med; 1981 Dec; 92(12):710-1. PubMed ID: 7326421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies and human tumours: pathological and clinical aspects.
    Neville AM; Gusterson BA
    Eur J Cancer Clin Oncol; 1985 Mar; 21(3):355-69. PubMed ID: 2408896
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic studies of human breast cancer. I. Serum reactivity against a lymphoid cell line (Belev) derived from a breast cancer patient as detected by complement-fixation test.
    Chan SP; Maca RD; Levine PH; Ting RC
    J Natl Cancer Inst; 1971 Sep; 47(3):511-7. PubMed ID: 5157574
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential pathological application of immunocytochemical methods to the detection of micrometastases.
    Sloane JP; Ormerod MG; Neville AM
    Cancer Res; 1980 Aug; 40(8 Pt 2):3079-82. PubMed ID: 7397703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic pitfalls in mammary pathology. Case 8. Breast metastases of a malignant melanoma].
    Dauplat MM; Penault-Llorca F
    Ann Pathol; 2009 Jun; 29(3):228-32. PubMed ID: 19619831
    [No Abstract]   [Full Text] [Related]  

  • 16. [CA 15-3 in breast cancer--specificity and diagnostic potential].
    Zito GA; Callipari S; Capuano S; Colella C; Cinque P; Gambardella A; Sacchettino A; Verza M; Varricchio M
    Boll Soc Ital Biol Sper; 1988 Jul; 64(7):667-70. PubMed ID: 3228513
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of human mammary epithelial antigens (HME-Ags) in breast cancer diagnosis.
    Ceriani RL; Orthendahl D; Sasaki M; Kaufman L; Miller S; Wara WM; Peterson JA
    Cancer Detect Prev; 1981; 4(1-4):603-9. PubMed ID: 7349827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer.
    Lu H; Goodell V; Disis ML
    J Proteome Res; 2008 Apr; 7(4):1388-94. PubMed ID: 18311901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of epithelial antigens in diagnosis and staging of breast cancer].
    Artamonova EV; Tupitsyn NN; Kadagidze ZG; Letiagin VP; Ermilova VD; Ognerubov NA; Panichenko AV; Riazantseva SN
    Arkh Patol; 2002; 64(6):13-5. PubMed ID: 12534220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of serum CA 72.4 in patients with non-tumor pathologies. Preliminary results].
    Sagredo E; Soriano A; Pombo L; Ruibal A
    Med Clin (Barc); 1989 Jan; 92(2):78-9. PubMed ID: 2709892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.